Michael J. Rivera-Robles

University of Puerto Rico, Medical Sciences Campus

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Overcoming Therapy Resistance in HER2‐positive Breast Cancer with the Dual Rac/Cdc42 Inhibitor MBQ‐167”.

Overcoming Therapy Resistance in HER2‐positive Breast Cancer with the Dual Rac/Cdc42 Inhibitor MBQ‐167

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.03931

N/A

0DataRank · unranked

0 citations

Michael J. Rivera-Robles, Paula Rocío Vigo‐Morales, Suranganie Dharmawardhane, Luis Velazquez‐Vega

Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models

Frontiers in Oncology(2023)10.3389/fonc.2023.1152458

N/A

0DataRank · unranked

10 citations

Michael J. Rivera-Robles, Linette Castillo‐Pichardo, Magaly Martínez‐Ferrer, Stephanie Dorta‐Estremera, Suranganie Dharmawardhane +1 more

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

Translational Oncology(2024)10.1016/j.tranon.2024.101928

N/A

0DataRank · unranked

5 citations

Michael J. Rivera-Robles, Annelis O. Sánchez-Álvarez, Pablo E. Vivas‐Mejía, Miciely Aponte-Reyes, Ailed Cruz‐Collazo +6 more